Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality. - Cirulli GO; Davis M; Stephens A; Chiarelli G; Finati M; Chase M; Tinsley S; Arora S; Sood A; Lughezzani G; Buffi N; Carrieri G; et al. (Cancer, 2025)